Opus Genetics, Stock Current Valuation
| IRD Stock | 1.05 0.04 3.67% |
Valuation analysis of Opus Genetics, helps investors to measure Opus Genetics,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Opus Genetics,'s Total Cash From Financing Activities is projected to decrease significantly based on the last few years of reporting.
Overvalued
Today
Please note that Opus Genetics,'s price fluctuation is extremely dangerous at this time. Calculation of the real value of Opus Genetics, is based on 3 months time horizon. Increasing Opus Genetics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Opus stock is determined by what a typical buyer is willing to pay for full or partial control of Opus Genetics,. Since Opus Genetics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Opus Stock. However, Opus Genetics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.05 | Real 0.99 | Hype 1.04 | Naive 1.13 |
The real value of Opus Stock, also known as its intrinsic value, is the underlying worth of Opus Genetics, Company, which is reflected in its stock price. It is based on Opus Genetics,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Opus Genetics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Opus Genetics, helps investors to forecast how Opus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opus Genetics, more accurately as focusing exclusively on Opus Genetics,'s fundamentals will not take into account other important factors: Opus Genetics, Company Current Valuation Analysis
Opus Genetics,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Opus Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Opus Genetics, is extremely important. It helps to project a fair market value of Opus Stock properly, considering its historical fundamentals such as Current Valuation. Since Opus Genetics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Opus Genetics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Opus Genetics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Opus Genetics, has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Opus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opus Genetics,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opus Genetics, could also be used in its relative valuation, which is a method of valuing Opus Genetics, by comparing valuation metrics of similar companies.Opus Genetics, is currently under evaluation in current valuation category among its peers.
Opus Fundamentals
| Revenue | 19.05 M | ||||
| Net Income | (9.99 M) | ||||
| Total Debt | 4.04 M | ||||
| Cash Flow From Operations | (1.11 M) | ||||
| Number Of Employees | 14 | ||||
| Total Asset | 53.95 M | ||||
| Retained Earnings | (81.47 M) | ||||
| Working Capital | 49.91 M | ||||
| Net Asset | 53.95 M |
About Opus Genetics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Opus Genetics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opus Genetics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opus Genetics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Opus Genetics, is a strong investment it is important to analyze Opus Genetics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Opus Genetics,'s future performance. For an informed investment choice regarding Opus Stock, refer to the following important reports:Check out Opus Genetics, Piotroski F Score and Opus Genetics, Altman Z Score analysis. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.